- Home
- NUVB vs BTE Comparison
NUVB vs BTE Comparison
Compare NUVB & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUVB | BTE |
|---|---|---|
| Founded | 2018 | 1993 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NUVB | BTE |
|---|---|---|
| Price | $8.62 | $3.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $9.63 | N/A |
| AVG Volume (30 Days) | 10.2M | ★ 24.8M |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $26,748,000.00 | ★ $2,194,819,404.00 |
| Revenue This Year | $283.17 | N/A |
| Revenue Next Year | $340.98 | N/A |
| P/E Ratio | ★ N/A | $16.57 |
| Revenue Growth | ★ 1137.19 | N/A |
| 52 Week Low | $1.54 | $1.36 |
| 52 Week High | $8.70 | $3.32 |
Technical Indicators
Market Signals| Indicator | NUVB | BTE |
|---|---|---|
| Relative Strength Index (RSI) | 76.08 | 68.01 |
| Support Level | $7.46 | $3.12 |
| Resistance Level | $8.24 | $3.28 |
| Average True Range (ATR) | 0.62 | 0.13 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 97.20 | 84.29 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.